TY - STD TI - European Association for the Study of the Liver. (2018) EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 69:182–236. https://doi.org/10.1016/j.jhep.2018.03.019 Epub 2018 Apr 5. Erratum in: J Hepatol. 2019 Apr;70(4):817. PMID: 29628281 ID - ref1 ER - TY - JOUR AU - Toro, A. AU - Pulvirenti, E. AU - Palermo, F. AU - Carlo, I. PY - 2012 DA - 2012// TI - Health-related quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatment JO - Surg Oncol VL - 21 UR - https://doi.org/10.1016/j.suronc.2011.10.005 DO - 10.1016/j.suronc.2011.10.005 ID - Toro2012 ER - TY - JOUR AU - Edeline, J. AU - Boucher, E. AU - Rolland, Y. PY - 2012 DA - 2012// TI - Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma JO - Cancer. VL - 118 UR - https://doi.org/10.1002/cncr.26255 DO - 10.1002/cncr.26255 ID - Edeline2012 ER - TY - JOUR AU - Omata, M. AU - Cheng, A. L. AU - Kokudo, N. PY - 2017 DA - 2017// TI - Asia-Pacific Clinical Practice Guidelines on the management of hepatocellular carcinoma: a 2017 update JO - Hepatol Int VL - 11 UR - https://doi.org/10.1007/s12072-017-9799-9 DO - 10.1007/s12072-017-9799-9 ID - Omata2017 ER - TY - JOUR AU - Leung, D. A. AU - Goin, J. E. AU - Sickles, C. AU - Raskay, B. J. AU - Soulen, M. C. PY - 2001 DA - 2001// TI - Determinants of postembolization syndrome after hepatic chemoembolization JO - J Vasc Interv Radiol VL - 12 UR - https://doi.org/10.1016/s1051-0443(07)61911-3 DO - 10.1016/s1051-0443(07)61911-3 ID - Leung2001 ER - TY - JOUR AU - Song, M. J. AU - Park, C. H. AU - Kim, J. D. PY - 2011 DA - 2011// TI - Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma: a case-control study of Asian patients JO - Eur J Gastroenterol Hepatol VL - 23 UR - https://doi.org/10.1097/MEG.0b013e328346d505 DO - 10.1097/MEG.0b013e328346d505 ID - Song2011 ER - TY - JOUR AU - Shin, S. W. PY - 2009 DA - 2009// TI - The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma JO - Korean J Radiol VL - 10 UR - https://doi.org/10.3348/kjr.2009.10.5.425 DO - 10.3348/kjr.2009.10.5.425 ID - Shin2009 ER - TY - JOUR AU - Kalva, S. P. AU - Iqbal, S. I. AU - Yeddula, K. PY - 2011 DA - 2011// TI - Transarterial chemoembolization with doxorubicin-eluting microspheres for inoperable hepatocellular carcinoma JO - Gastrointest Cancer Res VL - 4 ID - Kalva2011 ER - TY - JOUR AU - Liapi, E. AU - Geschwind, J. F. PY - 2011 DA - 2011// TI - Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization? JO - Cardiovasc Intervent Radiol VL - 34 UR - https://doi.org/10.1007/s00270-010-0012-y DO - 10.1007/s00270-010-0012-y ID - Liapi2011 ER - TY - JOUR AU - Liu, Y. S. AU - Ou, M. C. AU - Tsai, Y. S. PY - 2015 DA - 2015// TI - Transarterial chemoembolization using gelatin sponges or microspheres plus Lipiodol-doxorubicin versus doxorubicin-loaded beads for the treatment of hepatocellular carcinoma JO - Korean J Radiol VL - 16 UR - https://doi.org/10.3348/kjr.2015.16.1.125 DO - 10.3348/kjr.2015.16.1.125 ID - Liu2015 ER - TY - JOUR AU - Yinglu, F. AU - Changquan, L. AU - Xiaofeng, Z. AU - Bai, L. AU - Dezeng, Z. AU - Zhe, C. PY - 2009 DA - 2009// TI - A new way: alleviating postembolization syndrome following transcatheter arterial chemoembolization JO - J Altern Complement Med VL - 15 UR - https://doi.org/10.1089/acm.2008.0093 DO - 10.1089/acm.2008.0093 ID - Yinglu2009 ER - TY - JOUR AU - Dhand, S. AU - Gupta, R. PY - 2011 DA - 2011// TI - Hepatic transcatheter arterial chemoembolization complicated by postembolization syndrome JO - Semin Intervent Radiol VL - 28 UR - https://doi.org/10.1055/s-0031-1280666 DO - 10.1055/s-0031-1280666 ID - Dhand2011 ER - TY - JOUR AU - Llovet, J. M. AU - Bruix, J. PY - 2003 DA - 2003// TI - Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival JO - Hepatology. VL - 37 UR - https://doi.org/10.1053/jhep.2003.50047 DO - 10.1053/jhep.2003.50047 ID - Llovet2003 ER - TY - JOUR AU - Lammer, J. AU - Malagari, K. AU - Vogl, T. PY - 2010 DA - 2010// TI - Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study JO - Cardiovasc Intervent Radiol VL - 33 UR - https://doi.org/10.1007/s00270-009-9711-7 DO - 10.1007/s00270-009-9711-7 ID - Lammer2010 ER - TY - JOUR AU - Baere, T. AU - Arai, Y. AU - Lencioni, R. PY - 2016 DA - 2016// TI - Treatment of liver tumors with Lipiodol TACE: technical recommendations from experts opinion JO - Cardiovasc Intervent Radiol VL - 39 UR - https://doi.org/10.1007/s00270-015-1208-y DO - 10.1007/s00270-015-1208-y ID - Baere2016 ER - TY - JOUR AU - Lencioni, R. AU - Baere, T. AU - Burrel, M. PY - 2012 DA - 2012// TI - Transcatheter treatment of hepatocellular carcinoma with doxorubicin-loaded DC bead (DEBDOX): technical recommendations JO - Cardiovasc Intervent Radiol VL - 35 UR - https://doi.org/10.1007/s00270-011-0287-7 DO - 10.1007/s00270-011-0287-7 ID - Lencioni2012 ER - TY - JOUR PY - 2013 DA - 2013// TI - World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects JO - JAMA. VL - 310 UR - https://doi.org/10.1001/jama.2013.281053 DO - 10.1001/jama.2013.281053 ID - ref17 ER - TY - STD TI - Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the Study of the Liver. J Hepatol 35:421–430 https://doi.org/10.1016/s0168-8278(01)00130-1 ID - ref18 ER - TY - JOUR AU - Yang, H. AU - Seon, J. AU - Sung, P. S. PY - 2017 DA - 2017// TI - Dexamethasone prophylaxis to alleviate postembolization syndrome after transarterial chemoembolization for hepatocellular carcinoma: a randomized, double-blinded, placebo-controlled study JO - J Vasc Interv Radiol VL - 28 UR - https://doi.org/10.1016/j.jvir.2017.07.021 DO - 10.1016/j.jvir.2017.07.021 ID - Yang2017 ER - TY - JOUR AU - Tacher, V. AU - Radaelli, A. AU - Lin, M. AU - Geschwind, J. PY - 2015 DA - 2015// TI - How I do it: cone-beam CT during transarterial chemoembolization for liver cancer JO - Radiology VL - 274 UR - https://doi.org/10.1148/radiol.14131925 DO - 10.1148/radiol.14131925 ID - Tacher2015 ER - TY - JOUR AU - Hartrumpf, K. J. AU - Marquardt, S. AU - Werncke, T. PY - 2018 DA - 2018// TI - Quality of life in patients undergoing repetitive TACE for the treatment of intermediate stage HCC JO - J Cancer Res Clin Oncol VL - 144 UR - https://doi.org/10.1007/s00432-018-2704-7 DO - 10.1007/s00432-018-2704-7 ID - Hartrumpf2018 ER - TY - JOUR AU - Price, D. D. AU - McGrath, P. A. AU - Rafii, A. AU - Buckingham, B. PY - 1983 DA - 1983// TI - The validation of visual analogue scales as ratio scale measures for chronic and experimental pain JO - Pain. VL - 17 UR - https://doi.org/10.1016/0304-3959(83)90126-4 DO - 10.1016/0304-3959(83)90126-4 ID - Price1983 ER - TY - STD TI - Common Terminology Criteria for Adverse Events (CTCAE). In: Cancer Therapy Evaluation Program (CTEP). https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm#ctc_50.%20Accessed%2029%20Nov%202020. Accessed 28 Jan 2021. UR - https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm#ctc_50.%20Accessed%2029%20Nov%202020 ID - ref23 ER - TY - JOUR AU - Miksad, R. A. AU - Ogasawara, S. AU - Xia, F. AU - Fellous, M. AU - Piscaglia, F. PY - 2019 DA - 2019// TI - Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study JO - BMC Cancer VL - 19 UR - https://doi.org/10.1186/s12885-019-5989-2 DO - 10.1186/s12885-019-5989-2 ID - Miksad2019 ER - TY - JOUR AU - Favelier, S. AU - Boulin, M. AU - Hamza, S. PY - 2013 DA - 2013// TI - Lipiodol trans-arterial chemoembolization of hepatocellular carcinoma with idarubicin: first experience JO - Cardiovasc Intervent Radiol VL - 36 UR - https://doi.org/10.1007/s00270-012-0532-8 DO - 10.1007/s00270-012-0532-8 ID - Favelier2013 ER - TY - JOUR AU - Lencioni, R. PY - 2013 DA - 2013// TI - New data supporting modified RECIST (mRECIST) for hepatocellular carcinoma JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-3796 DO - 10.1158/1078-0432.CCR-12-3796 ID - Lencioni2013 ER - TY - JOUR AU - Gillmore, R. AU - Stuart, S. AU - Kirkwood, A. PY - 2011 DA - 2011// TI - EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization JO - J Hepatol VL - 55 UR - https://doi.org/10.1016/j.jhep.2011.03.007 DO - 10.1016/j.jhep.2011.03.007 ID - Gillmore2011 ER - TY - JOUR AU - Ikeda, M. AU - Arai, Y. AU - Park, S. J. PY - 2013 DA - 2013// TI - Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea JO - J Vasc Interv Radiol VL - 24 UR - https://doi.org/10.1016/j.jvir.2013.01.003 DO - 10.1016/j.jvir.2013.01.003 ID - Ikeda2013 ER - TY - JOUR AU - Piscaglia, F. AU - Tovoli, F. AU - Pini, P. AU - Salvatore, V. PY - 2018 DA - 2018// TI - A new horizon in the prevention of the postembolization syndrome after transcatheter arterial chemoembolization for hepatocellular carcinoma JO - Hepatology. VL - 67 UR - https://doi.org/10.1002/hep.29517 DO - 10.1002/hep.29517 ID - Piscaglia2018 ER - TY - JOUR AU - Lee, S. H. AU - Hahn, S. T. AU - Park, S. H. PY - 2001 DA - 2001// TI - Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration JO - Cardiovasc Intervent Radiol VL - 24 UR - https://doi.org/10.1007/s00270-001-0073-z DO - 10.1007/s00270-001-0073-z ID - Lee2001 ER - TY - JOUR AU - Malagari, K. AU - Pomoni, M. AU - Kelekis, A. PY - 2010 DA - 2010// TI - Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma JO - Cardiovasc Intervent Radiol VL - 33 UR - https://doi.org/10.1007/s00270-009-9750-0 DO - 10.1007/s00270-009-9750-0 ID - Malagari2010 ER - TY - STD TI - Facciorusso A, Bellanti F, Villani R et al (2016) Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: a meta-analysis of randomized trials. United European Gastroenterol J 5:511–518. https://doi.org/10.1177/2050640616673516 ID - ref32 ER - TY - JOUR AU - Mauri, G. AU - Varano, G. AU - Orsi, F. PY - 2016 DA - 2016// TI - TAE for HCC: when the old way is better than the new ones!!! JO - Cardiovasc Intervent Radiol VL - 39 UR - https://doi.org/10.1007/s00270-016-1340-3 DO - 10.1007/s00270-016-1340-3 ID - Mauri2016 ER - TY - JOUR AU - Brown, K. AU - Do, R. AU - Gonen, M. PY - 2016 DA - 2016// TI - Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/jco.2015.64.0821 DO - 10.1200/jco.2015.64.0821 ID - Brown2016 ER -